S�zary-type cutaneous T-cell leukaemia. Response to Winkelmann regimen.

Authors

  • C C Harland
  • M Balsitis
  • L G Millard

DOI:

https://doi.org/10.2340/0001555570251253

Abstract

A 37-year-old woman presented with an aggressive leukaemic form of small T-cell Sézary syndrome. Despite this unusually malignant variant of the disease, there was a dramatic response to a modified Winkelmann regimen of chlorambucil and prednisolone, and a useful, sustained remission of 7 months. The Winkelmann regimen remains an important and relatively non-toxic chemotherapeutic option for palliation of advanced Sézary syndrome.

Downloads

Download data is not yet available.

Downloads

Published

1990-05-01

How to Cite

Harland, C. C., Balsitis, M., & Millard, L. G. (1990). S�zary-type cutaneous T-cell leukaemia. Response to Winkelmann regimen. Acta Dermato-Venereologica, 70(3), 251–253. https://doi.org/10.2340/0001555570251253

Issue

Section

Articles